|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
| The latest generation of continuous electrodeionisation modules is changing the way highpurity water is commercially produced. The development of these modules was driven by one particular industry, the semiconductor industry, yet the benefits of this technology are certainly applicable in pharmaceutical manufacturing, advises Steve Willis at Ionpure
One of the many benefits of continuous electrodeionisation (CEDI) is the fact that the chemical waste created in conventional ion exchange pre-treatment is eliminated. The new breed of CEDI system offers a clean, environmentally superior alternative to chemically regenerated, mixed bed ion exchange plant, while matching it in performance.
Although clearly advantageous, neither the green aspect of the new technology nor its low operating cost have been key factors in meeting the needs of semiconductor production. The stringent demands on water purity already made by the microelectronics industry in general have intensified with the increasing complexity of microprocessor chips. Before CEDI was introduced to the industry, it relied heavily on mixed bed systems for ion removal.
However, in semiconductor fabrication processes, the use of conventional mixed bed deionisation for producing ultrapure water has its drawbacks, due to fluctuations in produced water quality. This is caused by exhaustion and regeneration of ion exchange beds. As CEDI, by definition, is free from regeneration, it is free from this fluctuation, and it is becoming increasingly competitive with conventional mixed bed DI, especially due to improved module performance, increasing module reliability and lowering the overall cost of ownership of CEDI systems.
Product water specifications for CEDI technologies are typically in the range of 10-16 megohm-cm with removal of weakly dissociated species such as silica and boron in the 90- 98 per cent range. This is sufficient for many industrial uses, including water production in the pharmaceutical and power generation markets. However, this quality is not sufficient for use in the microelectronics industry which requires greater than 18 megohm-cm, with most species nondetectable. In this case, and in many applications where there is a stringent silica requirement, CEDI is followed by ion exchange polishing. |
Read full article from PDF >>
|
 |
 |
 |
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
Steve Willis is the European Business Manager for Ionpure, part of Siemens. A chemist by profession, Steve has 29
years’ experience in the industrial water treatment market, working mainly in the areas of marketing and sales
development across diverse geographies, including Europe, the US, the Middle East, and India. His experience of
electrodeionisation technology goes back to 1987, when he was active in the marketing and sales of the first units
of this type in Europe. Since then his career has been mostly in the high purity water sector, focusing on the
pharmaceutical, semiconductor and power generation industries. |
|
 |
 |
 |
|

 |
Industry Events |
 |
EMBALLAGE 2012
19-22 November 2012, Paris Nord Villepinte, France
EMBALLAGE has clearly delineated sectors to make the decision-maker’s task easier when visiting and to highlight all the industry’s know-how: machinery and packaging for the food and cosmetics sectors, health solutions and luxury packaging and containers, etc. Hence, EMBALLAGE provides a bespoke solution for each industry
More info >> |
|
 |
News and Press Releases |
 |
Prism Ideas and dMetrics Launch Pioneering Service Analysing Patient–Reported Action, Behaviours and Outcomes with Social Media
Prism Ideas, the multi-national medical marketing and drug development consultants, today announced its collaboration with dMetrics, experts in identifying decisions made by millions of patients online, to launch a pioneering analysis service to evaluate patient healthcare outcomes reported within social media. Combining expertise in language analytics and healthcare, the two companies are interrogating social media to determine patient actions and insights, profiling patient needs, symptoms and response to treatment.
More info >> |
|
|